Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
This study is currently recruiting participants.
Study NCT00559312 Information provided by Queen's University
First Received: November 14, 2007 Last Updated: October 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
COPD
Additional conditions recognized in this trial
Pulmonary Disease, Chronic Obstructive
More general conditions related to this trial
Lung Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases
Interventions listed in this trial
fluticasone/salmeterol combination
placebo
Additional drug interventions recognized in this trial
Albuterol
Fluticasone
Salmeterol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Respiratory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
Queen's University
GlaxoSmithKline
Back to top of Main Content
